All things considered, data from cell lines enabled the identification of the group of patients among which a high WWOX expression with simultaneously elevated expression of other genes (herein: POLE4 and HSF2BP) did not bring prognostic benefits and may be related to the more cancer-promoting profile. This evidence concerns the gene HSF2BP and cancer.